Botryosphaeran reduces hepatic steatosis and dyslipidaemia , and glucose intolerance in diet-induced obese rats through activation of AMP-activated protein kinase ( AMPK ) and the expression of the Forkhead transcription factor , FOXO3a , in adipose tissue .